The Krembil Research Institute and the Globe and Mail have teamed up for a three-part magazine project designed to highlight the tremendous achievements of our science and research programs. One of these magazines is devoted to the Arthritis Research Program at UHN and is now available online.
Read Arthritis magazine »
In the Arthritis Program, our divisions conduct important research to assist our patients. Learn more about research underway in our:
Krembil Research Institute is the research arm of Toronto Western Hospital. Krembil scientists investigate the causes of arthritis and associated degenerative diseases and explore therapies.
Researchers at the University Health Network and the University of Toronto are conducting the first trial in North America investigating the safety of stem cells for the treatment of moderate to severe osteoarthritis of the knee.
Twelve patients who meet the study eligibility criteria will be enrolled.
If you are between the ages of 40-65, have a diagnosis of knee arthritis and are interested in being assessed for eligibility, please have your doctor refer you to one of our orthopaedic surgeons for an appointment. If you have any questions, please contact us at StemCells4Arthritis@uhn.ca or 416 603 5800 ext. 6109.
As Canada’s largest research hospital, UHN has a proud history of innovative research and important discoveries. Learn about the full scope of
our research »
Our researchers benefit from the support of donors who contribute to our partner foundation, Toronto General & Western Hospital Foundation.
Learn more about